Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Chapter 1 Epidemiology of Cardio-Oncology -- Chapter 2 Cardiotoxicity of Anticancer Therapies -- Chapter 3 Screening and Monitoring for Cardiotoxicity during Cancer Treatment -- Chapter 4 Management of Chemotherapy-Associated Cardiomyopathy -- Chapter 5 Treatment of hypertension in patie…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr Missing | Available |
Table of Contents:; I OVERVIEW -- II DIAGNOSTIC STUDIES -- III NERVOUS SYSTEM INVOLVEMENT OF SYSTEMIC CANCERS -- IV NEUROLOGICAL COMPLICATIONS OF CANCER -- V NEUROLOGICAL COMPLICATIONS OF CANCER THERAPY -- NEUROLOGICAL COMPLICATIONS OF SPECIFIC MALIGNANCIES -- VII NEUROLOGICAL COMPLICATIONS IN LONG…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
Version 4.0 published: May 28, 2009 (v4.03: June14, 2010)."
Table of Contents:; I BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY -- BIOLOGIC AND PHARMACOLOGIC BASIS OF CANCER CHEMOTHERAPY --BIOLOGIC BASIS OF MOLECULAR TARGETED THERAPY -- PRINCIPLES OF CANCER IMMUNOTHERAPY -- SYSTEMATIC ASSESSMENT OF THE PATIENT W…
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Table of Contents:; What is complementary and alternative medicine, and can it be used safely? -- Types of complementary and alternative therapies -- Herbs, vitamins, and supplements -- Symptom management with complementary and alternative medicine -- CAM therapy use by site -- Healthy living.
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 3-10 June 2014.
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17-24 March, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |